Diabetes and obesity share common mechanisms modifying AD risk, such as IR-mediated GSK3β activation, AGE-mediated Aβ production and peripheral inflammation-mediated neuroinflammation. Here, GSK3B is linked to obesity due to melanocortin 4 receptor deficiency.